Dr. Reddys Q3 Earnings and Revenues Surpass Estimates - Zacks Investment Research
| RDDA Stock | EUR 13.50 0.20 1.46% |
Roughly 62% of Dr Reddys' investor base is looking to short. The analysis of current outlook of investing in Dr Reddys Laboratories suggests that many traders are alarmed regarding Dr Reddys' prospects. The current market sentiment, together with Dr Reddys' historical and current headlines, can help investors time the market. In addition, many technical investors use Dr Reddys Laboratories stock news signals to limit their universe of possible portfolio assets.
Dr Reddys stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of RDDA daily returns and investor perception about the current price of Dr Reddys Laboratories as well as its diversification or hedging effects on your existing portfolios.
RDDA |
Dr. Reddys Q3 Earnings and Revenues Surpass Estimates Zacks Investment Research
Read at news.google.com
 |
Dr Reddys Fundamental Analysis
We analyze Dr Reddys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Reddys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Dr Reddys is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Dr Reddys Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dr Reddys stock to make a market-neutral strategy. Peer analysis of Dr Reddys could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics with similar companies.
Peers
Dr Reddys Related Equities
| 51A | American Public | 1.94 | ||||
| SQE | Strategic Education | 1.60 | ||||
| AF4 | Hanover Insurance | 0.62 | ||||
| G4A | GEAR4MUSIC | 0.54 | ||||
| ZFI1 | Zurich Insurance | 0.69 | ||||
| S49 | Singapore Reinsurance | 1.16 | ||||
| IZZ | TAL Education | 2.58 | ||||
| 0UI | United Insurance | 5.76 |
Complementary Tools for RDDA Stock analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |